University of Kansas Cancer Center-Westwood

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery	Resectable Non-small Cell Lung Cancer	Active, not recruiting	Phase 2	2026-08-10		NCT06161441
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)	Bronchiolitis Obliterans, Digestive System Diseases, Fibrosis, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sclerosis, bronchial disorder, bronchiolitis, bronchiolitis obliterans syndrome, bronchitis, cryptogenic organizing pneumonia, graft versus host disease, immune system disorder, liver disorder, lung disorder, obstructive lung disease, respiratory system disorder, respiratory tract infectious disorder	Recruiting	Phase 2	2025-12-15		NCT06619561

Clinical trials